MHC Class II Molecules and Presentation to CD4+ Cells

MHC class II molecules display peptides derived from proteins taken up from outside the cell and present them to CD4+ helper T cells. Their expression is largely confined to professional antigen-presenting cells, such as dendritic cells, macrophages, and B cells. Through class II presentation, the immune system mounts and coordinates responses against extracellular pathogens and orchestrates help for antibody production.

Definition

An MHC class II molecule is a heterodimer of two polymorphic transmembrane chains (alpha and beta) that binds peptides in a groove open at both ends and presents them, typically on professional antigen-presenting cells, to CD4+ T cells.

Scope

This topic covers the structure of the class II heterodimer, its open-ended peptide-binding groove, the endosomal loading pathway involving the invariant chain and HLA-DM, and presentation to CD4+ T cells. It is reference material on molecular immunology, not clinical or transplantation guidance.

Core questions

• How does the open-ended class II groove differ from the closed class I groove?
• Which cells express MHC class II and why?
• How does the invariant chain and HLA-DM control class II peptide loading?
• How does class II presentation to CD4+ T cells shape helper responses?

Key concepts

• Alpha and beta chain heterodimer
• Open-ended peptide-binding groove
• Exogenous (endosomal) antigen pathway
• Invariant chain (Ii) and CLIP
• HLA-DM-catalysed peptide editing
• Professional antigen-presenting cells
• CD4+ helper T-cell recognition

Mechanisms

The class II alpha and beta chains each contribute one membrane-distal domain to a groove that is open at both ends, so it can bind longer peptides (often 13-25 residues) that extend beyond the groove. Newly assembled class II is occupied by the invariant chain, which blocks premature peptide loading and directs the molecule to endosomal compartments; there the invariant chain is degraded to a remnant (CLIP), and the chaperone HLA-DM catalyses exchange of CLIP for high-affinity antigenic peptides generated from endocytosed proteins. The loaded molecule reaches the surface for inspection by CD4+ T cells. The 1993 crystal structure of HLA-DR1 established the open-groove architecture, and reviews detail the endosomal loading pathway and the central role of dendritic cells as presenters.

Clinical relevance

Class II presentation underlies CD4+ helper responses, antibody production, and many HLA-disease associations and is central to how dendritic cells initiate adaptive immunity. This entry is educational background on the pathway and is not a basis for individual diagnosis, HLA typing decisions, or treatment.

Evidence & guidelines

The structural and pathway content rests on landmark crystallography and peer-reviewed immunology reviews describing established cell biology rather than clinical guidelines.

History

Class II molecules were originally defined by their role in immune-response gene effects and in stimulating helper T cells. The 1993 HLA-DR1 structure by Brown and colleagues revealed the open-ended groove that distinguishes class II from class I and explained the longer peptides it presents. Work on the invariant chain and HLA-DM subsequently clarified how class II is loaded in the endosomal pathway, while studies of dendritic cells established their primacy as antigen-presenting cells.

Key figures

• Don Wiley
• Jack Strominger
• Peter Cresswell
• Ralph Steinman

Seminal works

• brown-1993
• roche-2015
• neefjes-2011

Frequently asked questions

Which cells express MHC class II?

Class II is expressed mainly by professional antigen-presenting cells such as dendritic cells, macrophages, and B cells, though its expression can be induced on other cell types by inflammatory signals.

Why can class II present longer peptides than class I?

The class II peptide-binding groove is open at both ends, so a peptide can extend out of the groove, allowing it to accommodate longer fragments than the closed class I groove.